Ayurcann Holdings Corp, a Canadian extraction company specializing in the processing of cannabis and hemp, said its common shares have been cross-listed for trading on the Frankfurt Stock Exchange, which is also referred to as Börse Frankfurt.
The Canadian cannabis company’s common shares will trade on the exchange under the symbol '3ZQ0.'
Facilitating the German listing is Steubing AG, a licensed specialist at cross-listing foreign companies in the German markets. The cross-listing specialist operates on all German stock exchanges and has direct online access to around 50 international trading centers.
READ: Ayurcann Holdings strikes agreement with Innocan Pharma to manufacture its CBD skincare and topical products in Canada
"We're excited to provide European investors with an opportunity to be a stakeholder and join our journey as we take significant strides towards becoming a leader in cannabis extraction and product manufacturing,” Igal Sudman, CEO of Ayurcann said in the release.
"Listing of our common shares on the Frankfurt Stock Exchange will provide the company tremendous visibility to European investors that will only seek to match our appetite for growth over the coming months."
As mentioned, Ayurcann aims to gain more exposure and access to larger capital pools through the listing. The inclusion of the company’s common shares is also anticipated “to broaden the shareholder base and lead to greater liquidity through increased trading activity in the company's shares," according to the firm.
The FSE is the world's third largest organized exchange-trading market in terms of turnover and dealings in securities, with more that 3,000 international companies listed on it.
Ayurcann will continue to be listed on the Canadian Securities Exchange under the ticker symbol "AYUR".
Contact the writer at georgia@proactiveinvestors.com
Follow her on Twitter @MissInformd